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Abstract
Background: Meningitis is the most severe manifestation of tuberculosis. It is largely unknown why some people
develop pulmonary TB (PTB) and others TB meningitis (TBM); we examined if the genetic background of infecting
M. tuberculosis strains may be relevant.
Methods: We whole-genome sequenced M. tuberculosis strains isolated from 322 HIV-negative tuberculosis patients
from Indonesia and compared isolates from patients with TBM (n = 106) and PTB (n = 216). Using a phylogeny-
adjusted genome-wide association method to count homoplasy events we examined phenotype-related changes
at specific loci or genes in parallel branches of the phylogenetic tree. Enrichment scores for the TB phenotype were
calculated on single nucleotide polymorphism (SNP), gene, and pathway level. Genetic associations were validated
in an independent set of isolates.
Results: Strains belonged to the East-Asian lineage (36.0%), Euro-American lineage (61.5%), and Indo-Oceanic
lineage (2.5%). We found no association between lineage and phenotype (Chi-square = 4.556; p = 0.207). Large
genomic differences were observed between isolates; the minimum pairwise genetic distance varied from 17 to
689 SNPs. Using the phylogenetic tree, based on 28,544 common variable positions, we selected 54 TBM and 54
PTB isolates in terminal branch sets with distinct phenotypes. Genetic variation in Rv0218, and absence of Rv3343c,
and nanK were significantly associated with disease phenotype in these terminal branch sets, and confirmed in the
validation set of 214 unpaired isolates.
Conclusions: Using homoplasy counting we identified genetic variation in three separate genes to be associated with
the TB phenotype, including one (Rv0218) which encodes a secreted protein that could play a role in host-pathogen
interaction by altering pathogen recognition or acting as virulence effector.
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Background
Tuberculosis (TB), caused by Mycobacterium tuberculosis,
remains a major global health problem [1]. Active TB
mostly affects the lungs but may also spread to other
organs. TB meningitis (TBM), which represents approxi-
mately 1–5% of all TB cases, is the most severe manifest-
ation of TB, resulting in death or neurological disability in
about half of those affected [2, 3]. It is largely unknown
why certain people develop pulmonary TB (PTB) and
others TBM. Host immune-related factors clearly play an
important role, as shown by the increased risk of TBM for
patients with advanced HIV infection, and the overrepre-
sentation of young children among TBM patients. Host
genetic factors may also play a role; single studies have
linked susceptibility to TBM with variation in candidate
genes [4–8].
Besides the host, genetic diversity of infecting M.
tuberculosis strains may also affect disease phenotype.
Even though M. tuberculosis is considered a clonal
organism, there is considerable genetic variation in the
genomes of infecting M. tuberculosis isolates [9, 10].
Epidemiological studies have reported significant differ-
ences among M. tuberculosis lineages in terms of
virulence [11, 12], transmission [9, 13, 14], progression
to active disease after infection [15], and response to
treatment [16, 17]. In vitro studies have supported these
findings by showing M. tuberculosis genotype-specific
differences in the human immune response [18–21].
Animal studies have shown that M. tuberculosis strains
differ in their ability to invade the central nervous
system (CNS). Five M. tuberculosis genes (Rv0311
(unknown function), Rv0805 (intermediary metabolism
and respiration), pknD (protein kinase D), Rv0986 (cell
wall and cell processes), and MT3280 (unknown func-
tion)) have been associated with invasion or survival in
the CNS but not in lung tissues in mice [22]. Especially
M. tuberculosis pknD was associated with invasion of
brain, but not lung epithelia in guinea pigs [23], as was
confirmed by another study showing that pknD vac-
cination offered significant protection against bacterial
dissemination to the brain in guinea pigs [24]. Simi-
larly, in mice, clinical isolates from TBM patients
disseminated extensively to cause meningitis, whereas
M. tuberculosis H37Rv and clinical isolates from PTB
patients did not [25]. In rabbits, production of phen-
olic glycolipid has been linked with the increased pro-
pensity of East-Asian/Beijing strains to cause TBM
[26]. Finally, four M. tuberculosis genes were crucial
for invading an artificial blood brain barrier in an in
vitro model using primary human brain microvascular
endothelial cells: PE-PGRS18 (unknown function),
Rv0987 (cell wall and cell processes), grcC2 (inter-
mediary metabolism and respiration), and PPE29 (un-
known function) [27].
Much less is known about the role of M. tuberculosis
genotype in TBM in humans. Most studies have exam-
ined associations of M. tuberculosis lineage with disease
phenotype. Compared to other lineages, strains belong-
ing the East-Asian lineage were associated with extrapul-
monary tuberculosis in one study [28], but not in
another [29], while other studies found no association of
M. tuberculosis lineage and disease localisation [30, 31].
Specifically looking at TBM, one study from Vietnam
found the Euro-American lineage to be associated with
PTB rather than TBM [32]. Only one study used whole
genome sequencing to compare strains from TBM and
PTB patients; large-scale and smaller genomic rear-
rangements, inversions, indels and single nucleotide
polymorphisms (SNPs) in eight cerebrospinal fluid
(CSF)-derived strains were not found in 69 comparison
respiratory strains isolated from independent sputum
samples [33]. In the current study, we used a much
larger set of isolates and a novel approach to examine
the effect of the M. tuberculosis genotype on the suscep-
tibility to TBM. We compared M. tuberculosis genomes
isolated from 216 PTB patients and 106 TBM patients
from Indonesia, all HIV-negative, to detect homoplastic
genetic variants associated with either PTB or TBM.
Results
Lineage distribution and phylogeny construction
M. tuberculosis isolates from established patient cohorts
in Bandung, Indonesia were selected for whole genome
sequencing. All available M. tuberculosis strains isolated
from HIV-negative TBM patients and randomly selected
strains from twice as many PTB patients from the same
setting were included, one strain was selected per patient.
Compared to the 216 PTB patients, the 106 TBM patients
were from a similar ethnic background, but slightly younger,
more often male, and more often previously treated for TB
(Additional file 1: Table S1). Based on a 62-SNP barcode
[34] 61.5% of the strains belonged to the Euro-American
lineage (63.4% for PTB; 57.5% for TBM), 36% to the
East-Asian lineage (33.3% for PTB; 41.5% for TBM),
and 2.5% to the Indo-Oceanic lineage (3.2% for PTB;
0.9% for TBM). The lineage distribution did not differ
significantly for strains isolated from TBM compared
to PTB patients (Chi-square = 3.230; p = 0.199).
A phylogenetic tree was constructed based on 28,544
variable common nucleotide positions among the
322 M. tuberculosis isolates. The phylogeny showed that
the TBM phenotype was not restricted to a certain M.
tuberculosis lineage; instead it arose many times inde-
pendently (Fig. 1). In addition, the tree showed a high
degree of strain heterogeneity. On average, two strains
differed by about 1000 SNPs, and this pairwise distance
did not differ among PTB and TBM strains (data not
shown), indicating that there was equal genetic diversity
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within PTB and within TBM strains. In addition, the
minimum pairwise genetic distance varied from 17 to
689 SNPs (data not shown), indicating that there was no
clustering of strains (≤12 SNPs distance [35]). For TBM
strains the minimum genetic distance ranged from 17 to
1785, and for PTB strains from 31 to 803 SNPs (data
not shown).
TB phenotype-associated genetic variations
Genome-wide association approaches for bacteria can
broadly be categorised into allele counting and homo-
plasy counting methods [36]. Allele counting methods
are based on the overrepresentation of an allele at the
same site in cases relative to controls, introducing a risk
of false-positive findings due to population stratification.
Homoplasy counting on the other hand, counts repeated
and independently emerging mutations that occur more
often in branches of cases relative to controls. In the
current study, we used a two-step approach: in the dis-
covery phase, we used homoplasy counting by identify-
ing terminal branch sets (TBSs) to maximize power to
identify true associations with the TB disease phenotype,
uncorrected for multiple tests. In the validation phase
we examined associations identified in the discovery
phase using allele counting with correction for multiple
testing and for phylogenetic bias to distinguish true as-
sociations from false positives, and performed ancestral
reconstruction to remove possible phylogenetic bias. To
divide the genomes in a discovery and a validation set,
we identified isolates in terminal branch pairs, trios and
quartets (i.e. separated at a terminal or near terminal
branch in the phylogenetic tree) with distinct pheno-
types (Fig. 2). Genetic differences between isolates within
a TBS provide the strongest, homoplasy-corrected pos-
sible association with the phenotype.
The phylogenetic tree revealed a total of 47 TBSs con-
taining 108 paired strains: 54 TBM and 54 PTB strains
that make up the discovery set. The merged SNP lists con-
sisted of 6488 variable positions with the corresponding
nucleotides for the 108 strains (Additional file 2). Using
the homoplasy-based association analysis, we found indi-
vidual nucleotide positions, genes, or pathways where TB
Fig. 1 Phylogenetic tree of 322 M. tuberculosis strains isolated from TBM and PTB patients. Legend: The highlighted branches indicate the 108
strains in 47 terminal branch sets, together comprising the discovery set. The purple stars indicate the origin of the SNP in Rv0218 according to
the ancestral reconstruction. The grey, white, and black triangles indicate the isolates in which nanK and/or Rv3433c are absent
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disease phenotype-associated mutations repeatedly occur
in different branches of the phylogenetic tree. These in-
cluded 9 SNPs, 5 genes, and 1 pathway (Table 1).
We used the remaining 214 (52 TBM and 162 PTB)
isolates not belonging to any of the TBSs (validation set)
to verify these results. The discovery set showed a total
of 6488 different non-synonymous SNPs involving 6483
dimorphic sites and 5 trimorphic sites across 2778 genes;
the validation set a total of 12,211 different non-
synonymous SNPs involving 12,185 dimorphic sites and
26 trimorphic sites across 3359 genes (Additional file 3).
There was an overlap of 2694 non-synonymous SNPs
and 1564 affected genes. Out of 9 SNPs significantly as-
sociated with either TBM or PTB in the discovery set,
one was confirmed in the validation set; the mutation in
Rv0218. Similarly, out of 5 genes harbouring genetic
variation associated with the TB phenotype, Rv0218 was
validated in the validation set (Table 1, Additional file 4:
Figure S1 and Additional file 5: Figure S2). The pathway
(ethylbenzene degradation) identified in the discovery
set was not confirmed in the validation set.
To correct for potential phylogenetic bias in the valid-
ation set, we reconstructed the ancestral state for the
SNP in Rv0218 and compared the ratio of TBM vs. PTB
isolates after the occurrence of this particular SNP with
the ratio of TBM vs. PTB prior to the occurrence of this
SNP in the validation set (Fig. 1 and Additional file 6:
Figure S3). Three branches with back mutations (2
TBM, 1 PTB branch) were excluded from the analysis.
Among the 33 nodes / leaves where the SNP occurred,
the average unweighted proportion of TBM isolates
among the child branches was 44.7%; among 166 isolates
in the validation set not harbouring this SNP, 29 (17.5%)
were from TBM patients (Additional file 7: Table S2).
The Z-score for the difference between proportions
was − 3.83 (p < 0.001).
De novo genome assembly
Next, we used a reference-free de novo genome assembly
approach to examine associations between presence/ab-
sence of genes and the TB phenotype, and to study
sequences not present in the reference genome. The list
of annotated coding sequences for the 108 assembled
genomes in the discovery set contained 3032 distinct
genes that were present in at least one, but not all of the
strains (Additional file 8). The permutation analysis
revealed six genes that were significantly associated with
the TB phenotype. Two of these genes, Rv3433c and
nanK, were validated in the validation set: absence of
these genes was associated with TBM (Fig. 1, Table 2,
Additional file 9). Together with Rv0218 they bring the
total number of genes associated with the TB phenotype
to three.
Effect of detected SNPs on protein function and predicted
function of phenotype-associated genes
We used published algorithms to predict the effects of
identified mutations on protein structure and function.
The SNP in Rv0218, a protein predicted to have trans-
membrane helices, likely leads to a decrease of stability
of the protein (Additional file 10: Table S3). For
Rv3433c, and nanK no transmembrane helices or signal-
ling peptides were predicted.
Discussion
To determine whether M. tuberculosis genetic variation
is associated with the TB disease phenotype, we com-
pared M. tuberculosis whole genome sequences from
a b
Fig. 2 Homoplasy-based association analysis; detection of mutations occurring along disparate locations in the phylogenetic tree. Legend: (a)
schematic example of a tree containing two terminal branch sets (TBSs) with a homoplastic SNP. b Schematic overview of the composition of
the 47 terminal branch sets
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216 PTB and 106 TBM patients and searched for homoplas-
tic mutations. We identified three genes in M. tuberculosis
(Rv0218, Rv3433c, and nanK) to be associated with either
TBM or PTB. Previous experimental studies have assessed
the importance of Rv0218. This secretome gene encodes for
a protein with multiple predicted transmembrane regions
and a C-terminal molybdopterin binding domain that is
often found in oxidoreductases and was shown to be essen-
tial for M. tuberculosis in vivo growth in C57BL/6 J mouse
spleen [37]. The SNP in Rv0218 is predicted to decrease the
stability of the respective protein. Secretome genes poten-
tially influence pathogen recognition and host-pathogen
interaction [38]. If mutations in these genes alter the appear-
ance of the M. tuberculosis surface, this could provide a
mechanism by which M. tuberculosis could evade the im-
mune response and enable dissemination to extrapulmonary
sites. Secretome genes are more likely to contain false-
positive associations as they are under selective pressure
from the immune system and phages [39]. How Rv3433c
and nanK could be related to the TB phenotype is not
Table 2 Significant genes identified by the de novo genome assembly analysis
Discovery dataset (n = 108) Validation dataset (n = 214)
Strains with CDS present (N) Strains with CDS present (N)
Coding sequence TBM (n = 54) PTB (n = 54) P-value TBM (n = 52) PTB (n = 162) P-value^
Bifunctional NAD(P)H-hydrate repair enzyme Nnr (Rv3433c) 36 47 0.011 34 144 0.002
TMAO/DMSO reductase 46 53 0.016 49 152 0.592
Antitoxin/MT2731 33 44 0.017 37 130 0.206
NPCBM-associated, NEW3 domain of alpha-galactosidase 15 6 0.022 14 19 0.063
Oxidoreductase molybdopterin binding domain protein 11 3 0.028 7 13 0.197
N-acetylmannosamine kinase (nanK) 44 51 0.036 44 157 0.001
NOTE. P-values are based on permutation analysis; bold p-values indicate validated significant enrichment
^ P-value thresholds in the validation set were Bonferroni-corrected for multiple testing by dividing them by the number of top hits in the discovery set: p < 0.05/6
Table 1 Significant SNPs, genes, and pathways identified by homoplasy counting
Discovery dataset (n = 108) Validation dataset (n = 214)
SNP-level Strains with SNP (N) Strains with SNP (N)
Gene (Rv-number) Nucleotide change TBM (n = 54) PTB (n = 54) P-value TBM (n = 52) PTB (n = 162) P-value^
Unnamed (Rv0218) 261,869CT 25 10 0.002 21 24 0.001
PPE54 (Rv3343c) 3736,628TG 22 35 0.008 27 87 0.472
PEPGRS19 (Rv1067c) 1,190,093AC 2 11 0.01 5 18 0.487
PEPGRS44 (Rv2591) 2922,848AT 0 6 0.01 2 7 0.625
PPE3 (Rv0280) 340,372TC 2 10 0.025 4 13 0.589
PEPGRS9 (Rv0746) 836,272AG 7 1 0.029 3 9 0.603
PEPGRS26 (Rv1441c) 16,18,978TC 0 5 0.032 2 3 0.369
Unnamed (Rv0064) 713,36GC 24 34 0.034 29 98 0.355
PEPGRS18 (Rv0980c) 1095,644CT 0 4 0.044 2 2 0.238
Gene-level SNPs in gene (N) SNPs in gene (N)
Gene (Rv number) TBM PTB P-value TBM PTB P-value
PEPGRS19 (Rv1067c) 2 13 0.004 5 22 0.318
Unnamed (Rv0218) 27 11 0.007 21 32 0.001
PEPGRS26 (Rv1441c) 0 5 0.031 2 4 0.491
glmS (Rv3436c) 0 5 0.031 0 0 n.a.
Unnamed (Rv3740c) 0 4 0.05 3 0 0.011
Pathway-level Genes with mutation (N) Genes with mutation (N)
Pathway name TBM PTB P-value TBM PTB P-value
Ethylbenzene degradation 68 54 0.032 65 224 0.071
NOTE. P-values are based on permutation analysis; bold p-values indicate validated, Bonferroni-corrected significant enrichment
^ P-value thresholds in the validation set were Bonferroni-corrected for multiple testing by dividing them by the number of top hits in the discovery set: SNP-
level: p < 0.05/9; gene-level: p < 0.05/5; pathway-level: p < 0.05/1
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obvious,although functions have been predicted based on
homology detection.
To our knowledge, this is only the second attempt to
relate M. tuberculosis genetic variation to the TB disease
phenotype in humans on a genome-wide scale. The
other study, by Saw et al. showed large-scale rearrange-
ments, short translocations, inversions, indels and SNPs in
eight strains cultured from CSF [33]. Non-synonymous
SNPs in eight genes (embR, lppD, PE-PGRS10, PE-PGRS19,
PE-PGRS21, PE-PGRS49, PPE58, and Rv0278c) were found
in at least four of the eight CSF-derived strains, and in none
of 69 strains isolated from sputum [33]. We did not
confirm this in our set of isolates, although PE-PGRS19 was
associated with the TB phenotype in the discovery set.
Moreover, we used a two-step approach, based on homo-
plasy counting as well as allele counting with a correction
for phylogenetic bias to find mutations associated with the
TB phenotype, and we performed ancestral reconstruction
for the most discriminative SNP. Unlike a previous study
from Vietnam [32], we found no association between M.
tuberculosis lineage and TBM. This is no surprise given the
genetic diversity even within M. tuberculosis lineages [9],
and the observed pattern of TBM isolates scattered across
the phylogenetic tree.
In concordance with previous findings [9], we found
considerable genetic diversity in M. tuberculosis in the
current study. Two isolates differed on average by 1000
SNPs, and this did not differ among PTB isolates and
among TBM isolates. In addition, we did not observe
any clustering, defined as two isolates differing by 12
SNPs or less [35]. The lack of clustering is probably a
result of the low sampling fraction in this urban setting
with thousands of incident TB cases each year.
Theoretically, two scenarios could explain the role of
M. tuberculosis genetic variation in the development of
TBM after infection with M. tuberculosis. First, upon
infection the M. tuberculosis strain may carry certain
mutations associated with dissemination and penetration
of the blood-brain barrier. Second, a subpopulation of
bacteria in the lungs of a PTB patient may develop such
mutations, though it was recently shown for bacterial
meningitis caused by S. pneumonia or N. meningitides
that there is no evidence for differential selection
between blood and CSF, and that any mutations between
these two niches is likely due to mutation hotspots or forms
of diversifying selection common to both niches [40]. How-
ever, similar to the findings of Saw et al. [33], the genetic
variants that we found to be associated with the TB disease
phenotype were not exclusive for TBM or PTB, nor were
they consistently present in all TBM or PTB strains. There-
fore it seems that genetic variants may be part of a com-
plex, multifactorial process leading to this devastating
manifestation of TB, in which the human genotype or
phenotype equally plays an important role [32, 41].
This is the second, and by far largest study using
whole genome sequencing to link M. tuberculosis geno-
type to TBM. In this large cohort of well-characterised
patients we studied strains from HIV-negative, adult
patients to control for the two most important known
risk factors for TBM. In addition, both patient groups
were similar with regard to gender, ethnicity, and previ-
ous episodes of TB. The de novo assembly adds to the
strengths of this study because it enabled us to examine
regions of the genome that do not map to the reference
genome, allowing the investigation of associations
between genetic variation in these genomic regions and
the TB disease phenotype. The homoplasy-based associ-
ation analysis has proven to be a successful method to
detect M. tuberculosis loci associated with a certain
phenotype (e.g. transmissible vs. non-transmissible,
drug-resistant vs. sensitive) [42, 43]. The major advan-
tage is that false-positive associations due to genetic
relatedness of strains with the same phenotype (i.e.
‘phylogenetic bias’) are filtered out, thereby increasing
statistical power to find true associations. In addition,
the ancestral reconstruction in the validation step ruled
out the possibility that the significant association for the
SNP in Rv0218 was due to population structure.
The current study has several limitations. Firstly, we
only focused on mutations in coding regions of the
genome, as they are more likely to have functional con-
sequences, but mutations in non-coding regions could
also affect function, for instance by transcriptional and
translational regulation of protein-coding sequences
[44]. Secondly, the large number of genetic variants
increases the risk of finding false-positive associations,
although homoplasy counting enabled us to filter out
many of these false-positives. We did not correct for
multiple testing in the discovery set, but we used a
validation set where we did correct for multiple testing
for confirmation. Lastly, whether bacteria developed
TBM-associated mutations before or after infecting a
patient remains unclear. One way to investigate this is to
compare the genomes of strains isolated from sputum
and CSF from the same patient. Unfortunately we did
not have the availability of paired isolates. Most TBM
patients were too ill to expectorate sputum.
Conclusions
We present evidence from a homoplasy-based associ-
ation analysis that three M. tuberculosis genes, including
Rv0218, a cell wall-associated and/or secretome gene,
are associated with the TB disease phenotype. These
findings serve as an important step forward in the quest
for an improved understanding of the mycobacterial
determinants of TB tissue tropism. Functional validation
studies are warranted to further explore the effect of
mutations in these genes on protein function.
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Methods
Patients and isolates
We used M. tuberculosis isolates from two established
cohorts of Indonesian patients with confirmed TB. The
first group consisted of adult patients (≥15 years old)
with TBM admitted at Hasan Sadikin Hospital between
2006 and 2013, with M. tuberculosis cultured from CSF.
The second group was randomly selected from a cohort of
culture-positive HIV-negative PTB patients (age ≥ 15 years)
from the same setting recruited between 2012 and
2015. All patients were tested for HIV, and those who
were HIV-positive were excluded.
Sequencing, alignment, and variant calling
Mycobacterial DNA was extracted from cultures using
cetyl trimethylammonium bromide (CTAB) or using
UltraClean® Microbial DNA Isolation Kit (MO BIO
Laboratories). A single isolate from each patient was
selected for sequencing. M. tuberculosis DNA was
sequenced on an Illumina HiSeq 2000 instrument using
2 × 100 bp paired-end reads at the Beijing Genome
Institute in Hong Kong. After sequencing, the raw
FASTQ sequence reads were filtered, including removing
of adapter sequences, contamination, and low quality
reads which have more than 10% N base calls, or where
more than 40% of the bases have a quality score ≤ 4.
Quality control statistics are shown in Additional file 11:
Table S4. Five TBM strains and four PTB strains were
contaminated, based on a low GC-content, and were
excluded from further analyses. Sequencing coverage
was determined using the FASTQC quality control tool
version 0.10.1. The proportion of bases sequenced with
a sequencing error rate of 1% or less per base ranged
from 93% to 97% per genome. The average coverage
depth for the remaining 322 sequenced strains was
121.1, and the average percentage of bases covered by at
least one read was 98.9%.
The sequence reads were aligned to reference strain
M. tuberculosis H37Rv, accession number NC_000962.3,
and variants were called using Breseq software, version
0.27.1 [45] using a minimum threshold of 30× coverage.
Mutations with low-quality evidence (i.e. possible mixed
read alignment) were not included. The Breseq variant
call output was converted to a tab-separated file for each
sequence using customized Python and R scripts that
are available upon request.
Phylogeny construction
A phylogeny was constructed to determine evolutionary
relationships of the isolates. We extracted all 29,199
variable positions across the 322 M. tuberculosis
sequences and concatenated them into a single align-
ment. Solely for the purpose of creating the phylogenetic
tree, SNPs occurring in PE/PPE genes and genes related
to mobile elements (genes listed in Additional file 12:
Table S5) were excluded to avoid any concern about
inaccuracies in the read alignment in these parts of the
genome. In addition, SNPs in an additional 40 genes
previously associated with drug resistance [46] were
removed to exclude the possibility that homoplasy of
drug resistance mutations would significantly affect the
phylogeny [47]. After applying these filters to the initial
set of 29,199 SNPs, the 28,544 remaining SNPs were
used to construct the phylogenetic tree using PhyML,
version 3.0 [48] using the HKY85 model with four
categories for the gamma distribution, and using a
hundred bootstraps.
To determine the lineage distribution of the strains
and to evaluate whether an association exists between
M. tuberculosis lineage and TB disease phenotype, we
determined the lineage for each of the 322 strains using
a 62-SNP barcode [34]. The resulting classification in the
main M. tuberculosis lineages also served as a quality check
for the generated Maximum Likelihood (ML)-phylogenetic
tree, as it enabled us to validate that isolates belonging to
the same lineage clustered together in the tree. A Chi-
square test was used to statistically test the association
betweenM. tuberculosis lineage and TB disease phenotype.
Homoplasy-based association test to identify associations
between M. Tuberculosis genotype and TB disease
phenotype
We used a two-step approach: in the discovery step we
aimed to maximize power by homoplasy counting, with-
out correction for multiple testing. In the subsequent
validation step, aimed to distinguish true associations
from false positives, we used allele counting with mul-
tiple testing correction, and performed ancestral recon-
struction to remove possible phylogenetic bias.
To divide the genomes in a discovery and a validation set,
we identified isolates in terminal branch pairs, trios and
quartets (i.e. separated at a terminal or near terminal
branch in the phylogenetic tree) with distinct phenotypes
(Fig. 2). These terminal branch sets (TBSs) together formed
the discovery set. These provide the strongest, homoplasy-
corrected possible association with the phenotype. We used
the remaining genomes to validate the association. For all
isolates in the TBSs, we listed the non-synonymous SNPs
to create a table with all variable positions in rows, the
paired isolates in columns, and the corresponding nucleo-
tide in the cells (Additional file 2). For every SNP, an en-
richment score was calculated using the following formula:
log
number of TBM isolates with SNP=total number of TBM isolatesð Þ þ 0:001
number of PTB isolates with SNP=total number of PTB isolatesð Þ þ 0:001
 
A permutation p-value for each SNP was calculated
by randomising the phenotypes over the isolates 1000
times.
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In parallel we grouped SNPs per gene, using the same
empirical randomisation strategy to assess association,
adjusted for gene length:
log
number of SNPs in gene in TBM isolates=gene lengthð Þ=total number of TBM isolatesð Þ þ 0:001
number of SNPs in gene in PTB isolates=gene lengthð Þ=total number of PTB isolatesð Þ þ 0:001
 
Similarly, we grouped genes with ≥1 SNP per M.
tuberculosis pathway according to PATRIC [49], and
calculated association using the aforementioned permu-
tation analysis, adjusted for the number of genes in a
particular pathway:
log
number of pathway genes with≥1 SNP in TBM isolates=unique gene countð Þ=total number of TBM isolatesð Þ þ 0:001
number of pathway genes with≥1SNP in PTB isolates=unique gene countð Þ=total number of PTB isolatesð Þ þ 0:001
 
Significance of associations was determined by calcu-
lating a permutation p-value through randomization of
the phenotypes over the isolates 1000 times. All calcula-
tions were performed with customized Perl scripts that
are available upon request.
We used the set of 214 strains that were not in TBSs to
validate candidate SNPs, genes, and pathways identified in
the discovery set, using the same permutation test as
described above for the discovery set. We used a p-value
threshold of 0.05 for the discovery set. The p-value thresh-
olds in the validation set were Bonferroni-corrected for
multiple testing by dividing them by the number of signifi-
cant (candidate) hits in the discovery set. To correct for
potential phylogenetic bias in the validation set, we
performed ancestral reconstruction for validated TB
phenotype-associated SNPs using FASTML [50] with
default parameters, and compared the proportion of TBM
vs. PTB isolates prior to (i.e. older than) and after (i.e.
younger than) the occurrence of the SNP in the validation
set. For each node / leave where the SNP occurred, we cal-
culated the proportion of TBM isolates among the child
branches and we calculated the (unweighted) average over
all of these nodes and leaves to determine the proportion
of TBM isolates after the SNP (Additional file 7: Table S2).
This way, every independent occurrence of the SNP
contributes equally to the analysis, regardless of the
number of child branches after the SNP, thus correcting
for phylogenetic bias. The significance of the difference in
proportion was determined by calculating the Z-score for
2 population proportions with accompanying p-value.
PE/PPE genes, a major challenge in the analysis of M.
tuberculosis whole genome sequences due to the repeti-
tive nature of these sequences, were included in the ana-
lysis. TB phenotype-associated SNPs in PE/PPE genes
were manually examined to confirm that they did not
fall within a repetitive region (for an example please see
Additional file 13: Figure S4).
De novo genome assembly
Sequence reads were de novo assembled using SPAdes,
version 3.6.1 [51] with default parameters. All assemblies
were evaluated, focussing on genome size, N50 length,
number of contigs and scaffolds, and GC-content. The
assembled genomes were annotated using Prokka,
version 1.11 [52] with default parameters. Completeness
and contamination of assemblies were determined with
CheckM version 1.0.5 [53]. The assembly statistics are
shown in Additional file 14. Presence or absence of
annotated genes was determined for the 108 assembled
genomes in the discovery set. An enrichment score per
gene was calculated based on the frequency of
occurrence in TBM vs. PTB strains using the following
formula:
log
number of TBM isolates with gene present=total number of TBM isolatesð Þ þ 0:001
number of PTB isolates with gene present=total number of PTB isolatesð Þ þ 0:001
 
Statistical significance was again determined based on
permutation by randomizing the phenotypes over the iso-
lates 1000 times. We repeated this permutation analysis
for the 214 genomes comprising the validation set, using
Bonferroni-adjusted p-value thresholds. For the genes
with a validated, significant enrichment for TBM or PTB,
we confirmed their absence in the respective genomes by
mapping the raw sequencing reads for these genomes
back to the H37Rv reference sequence of the gene
(Additional file 15: Figure S5), and visualized this with
integrative genomics viewer (IGV), version 2.3.32 [54].
Prediction of mutation effects
We used two algorithms to predict the effect of the
mutations on protein structure and function. I-Mutant
version 2.0, which predicts the protein stability change
upon single site mutation (http://folding.biofold.org/i-
mutant/i-mutant2.0.html) [55] and PolyPhen-2, which
predicts the possible impact of an amino acid substitu-
tion on the structure and function of a protein (http://
genetics.bwh.harvard.edu/pph2/) [56] to predict the
impact of the validated SNPs on protein structure and
function. In addition, we used TartgetP (http://
www.cbs.dtu.dk/services/TargetP/) [57] to predict the
subcellular location of the proteins encoded by the
validated genes, and TMHMM (http://www.cbs.dtu.dk/
services/TMHMM/) [58] to predict transmembrane
helices in these proteins.
Additional files
Additional file 1: Table S1. Description of baseline characteristics for
PTB and TBM patients. IQR, interquartile range; SD, standard deviation.
Data were missing for history of TB treatment (TBM, n = 7; PTB, n = 1);
ethnicity (TBM, n = 58; PTB = 2). (DOCX 58 kb)
Additional file 2: Merged SNP lists consisting of variable positions for
the 108 strains in the discovery set. File showing all common non-
synonymous SNPs in the 108 isolates in the discovery set, including their
p-value for association with the TB disease phenotype. (XLSX 2729 kb)
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Additional file 3: Merged SNP lists consisting of variable positions for the
214 strains in the validation set. File showing all common non-synonymous
SNPs in the 214 isolates in the validation set, including their p-value for
association with the TB disease phenotype. (XLSX 8758 kb)
Additional file 4: Figure S1. P-values of association between SNPs and TB
disease phenotype in the discovery and validation sets. Scatterplot showing the
p-values of the SNPs found in the discovery and the validation set. P-values in
the discovery set are shown on the x-axis; p-values in the validation set are
shown on the y-axis. Gene names are shown for SNPs significant in both the
discovery and validation set. (DOCX 82 kb)
Additional file 5: Figure S2. P-values of association between genes and TB
disease phenotype in the discovery and validation sets. Scatterplot showing the
p-values of the genes found in the discovery and the validation set. P-values in
the discovery set are shown on the x-axis; p-values in the validation set are
shown on the y-axis. Names are shown for genes significant in both the
discovery and validation set. (DOCX 66 kb)
Additional file 6: Figure S3. Phylogenetic tree of 322 M. tuberculosis
strains isolated from TBM and PTB patients. The highlighted branches
indicate the 108 strains in 47 terminal branch sets, together comprising
the discovery set. The purple stars indicate the origin of the SNP in
Rv0218 according to the ancestral reconstruction. The nucleotide for SNP
position 261,869 is indicated next to the leaf labels. (PDF 60 kb)
Additional file 7: Table S2. Ancestral reconstruction of SNP 261869TC in
Rv0218. Listed are the internal nodes and leaves where the SNP in Rv0218
occurred according to the ancestral reconstruction of the SNP. (DOCX 72 kb)
Additional file 8: Annotated coding sequences present in the 108 de
novo assembled genomes in the discovery set. Annotated coding
sequences present in at least one, but not in all of the 108 de novo
assembled genomes in the discovery set. (XLSX 1286 kb)
Additional file 9: Annotated coding sequences present in the 214 de
novo assembled genomes in the validation set. Annotated coding
sequences present in at least one, but not in all of the 214 de novo
assembled genomes in the validation set. (XLSX 1309 kb)
Additional file 10: Table S3. Protein prediction for genomic sites
associated with the TB disease phenotype. NA: No homologs of Rv0192 were
found therefore protein prediction was not possible. # I-mutant predicts free
energy changes of protein stability upon a point mutation under different
conditions. & PolyPhen predicts the possible impact of an amino acid
substitution on the structure and function of a human protein using
straightforward physical and comparative considerations. ^ TargetP predicts
the subcellular location of proteins based on the predicted presence of any
N-terminal signal peptides. * TMHMM predicts transmembrane helices in
proteins. (DOCX 57 kb)
Additional file 11: Table S4. Description of sequencing quality control
parameters and statistics. Displayed are different measures of sequencing
quality, used for the sequencing quality control check. (DOCX 208 kb)
Additional file 12: Table S5. PE / PPE genes and drug resistance genes
excluded for the phylogeny construction. Listed are the genes that were
excluded from the multiple alignment used to create the phylogenetic
tree. (DOCX 158 kb)
Additional file 13: Figure S4. Diagram demonstrating breseq calling a
SNP in the PE-PGRS1 gene. Displayed are 60 Illumina sequencing reads
mapping to the H37Rv reference genome (shown at the top and
bottom). Visual inspection of the SNP confirms that it does not occur in a
region containing uniformly lower base quality scores. (DOCX 1204 kb)
Additional file 14: De novo genome assembly statistics. File listing
different measures used to check the quality of the de novo genome
assemblies. (XLS 73 kb)
Additional file 15: Figure S5. Read alignment demonstrating the
absence of nanK. Displayed is the alignment of the raw sequencing reads
against the H37Rv nanK gene. No reads are mapping to this gene,
showing that it is absent in the sequenced genome. (DOCX 54 kb)
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